Are these two small-caps the cheapest high yield stocks around?

Rupert Hargreaves analyses two income plays that the market seems to be overlooking.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At the end of October last year, shares in Pendragon (LSE: PDG) one of the UK’s largest car dealers, slumped by more than 20% after the group warned on profits due to falling sales of new vehicles.

Even though the company achieved underlying operating profits of £48.5m in the first half of the year, it struggled to break even in the second half of 2017. When the results for the full year were eventually released, it reported a decline in earnings per share for the year of 4.2%.

Unfortunately, analysts are expecting earnings to decline a further 14% this year, but growth is expected to return in 2019 thanks to the company’s efforts to rebuild the business around used vehicle sales, automotive after-sales services and software. 

Software sales 

Pendragon’s Pinewood Technologies is a leading software provider in the motor industry, providing dealer management software for dealerships all over the world. Even though this division is relatively small compared to the overall group, it generates a disproportionate amount of profit and is still growing steadily. Software sales accounted for less than 0.4% of revenue in 2017 but 13% of operating profit. 

That being said, even though software sales will pick up some of the slack, there’s no getting away from the fact that the firm’s income is set to fall in 2018. Still, even with earnings due to come in 14% lower, City analysts believe the group’s dividend of 1.55p per share will continue to be covered twice by earnings per share. 

Management is also trying to sell Pendragon’s US dealerships, which could fetch £100m, wiping out almost all of the company’s debt.

These figures lead me to believe that the firm’s dividend yield of 6.2% is not going to be slashed anytime soon and the stock is a steal, changing hands at just seven times forward earnings.

A great opportunity 

Another income stock that I believe is too cheap to pass up right now is Photo-Me (LSE: PHTM)

Last month, shares in Photo-Me slumped after the company issued a profit warning thanks to slower than expected growth in one of its most important photo booth markets, Japan.

Part of the reason why the shares fell so heavily after its warning is that they looked quite expensive heading into the update. After years of explosive growth (net profit has more than doubled over the past five years), investors were expecting the good times to continue. The market was not expecting a profit warning. 

However, even though City analysts now expect to the company’s earnings per share to remain stagnant for the next two years, I believe this is an excellent opportunity for investors to snap up a high-yield share at a bargain price.

Indeed, right now shares in Photo-Me support a dividend yield of 7.1% and trade at a forward P/E of 12.6, the lowest valuation awarded to the stock since 2013. Management has already stated its commitment to the dividend following the profit warning, and with net cash of approximately £26m at the end of April, it really does look as if this market-beating dividend yield is here to stay.

Rupert Hargreaves owns shares in Pendragon. The Motley Fool UK has recommended Pendragon and Photo-Me International. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »